Publications by authors named "Neil Brickel"

Claim this Profile
O
Olaparib tolerability and common adverse-event management in patients with metastatic castration-resistant prostate cancer: Further analyses from the PROfound study.
Guilhem Roubaud, Mustafa Özgüroğlu, Nicolas Penel, Nobuaki Matsubara, Niven Mehra, Neil Brickel

Eur J Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of retigabine in adults with partial-onset seizures after long-term exposure: focus on unexpected ophthalmological and dermatological events.
Neil Brickel, Karen Hewett, Kirsty Rayner, Susan McDonald, Jeni De'Ath

Epilepsy Behav· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Collaboration in pharmacovigilance: lamotrigine and fatal severe cutaneous adverse reactions - a review of spontaneous reports.
Neil Brickel, Haris Shaikh, Andrew Kirkham, Greg Davies, Michelle Chalker

Ther Clin Risk Manag· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Survey of Prescriber Understanding of Risks Associated with Retigabine.
Lianna Ishihara, Anne Lewis, Sathish Kolli, Neil Brickel

Drugs Real World Outcomes· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physician and Pharmacist Understanding of the Risk of Urinary Retention with Retigabine (Ezogabine): A REMS Assessment Survey.
Lianna Ishihara, Melissa Beck, Sara Travis, Olusegun Akintayo, Neil Brickel

Drugs Real World Outcomes· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of the impact of urine handling procedures on interpretation of urinalysis findings and product safety in subjects treated with ezogabine.
Neil Brickel, Sarah Derossett, Mauro Buraglio, Christopher Evans, Siôn Jones

Ther Clin Risk Manag· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The urinary safety profile and secondary renal effects of retigabine (ezogabine): a first-in-class antiepileptic drug that targets KCNQ (K(v)7) potassium channels.
Neil Brickel, Paul Gandhi, Kevan VanLandingham, Janet Hammond, Sarah DeRossett

Epilepsia· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of lamotrigine on the PR interval in healthy subjects.
Ruth Dixon, Sarah Alexander, Neil Brickel

Br J Clin Pharmacol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis